What this research found
A 13-slide briefing on hantavirus for a scientifically curious general audience, built around the argument that the disease is as much an ecology, climate, behaviour, and surveillance story as a virology one. It moves from global epidemiology and the rodent-to-dust transmission route through United States case surveillance, the clinical course, and practical prevention. The deck synthesizes published work rather than presenting a new analysis.
- Hantaviruses cause roughly 200,000 infections a year worldwide and there is still no antiviral or vaccine approved by the FDA. Case fatality runs 35-50% for the pulmonary syndrome found in the Americas and 1-15% for Eurasian hemorrhagic fever with renal syndrome, and Andes virus remains the only hantavirus with documented person-to-person spread.
- The US burden is small but lethal and geographically lopsided: 890 cases reported from the start of surveillance in 1993 through 2023 — 859 pulmonary and 31 non-pulmonary — with 35% of reported cases fatal and 94% occurring west of the Mississippi River.
- Outbreaks track rainfall more closely than anything a clinician controls. Deer-mouse infection prevalence lags rodent density by 8 to 16 months, and 86% of European studies find that rising forest cover increases Puumala virus risk.
- Prevention is behavioural and specific: ventilate an enclosed space for 30 minutes, wet-clean with a 1:10 bleach solution, and wear an N95 respirator — never sweep, vacuum, or blow dust. The 2012 Yosemite tent-cabin cluster produced 10 confirmed cases.
- Care is supportive rather than curative. A placebo-controlled ribavirin trial was inconclusive for the pulmonary syndrome, while extracorporeal membrane oxygenation case series published since 2020 report 45-65% survival in severe disease.
How it was done
Published literature was synthesized across global epidemiology, rodent ecology, climate drivers, clinical management, and occupational prevention guidance, yielding 19 verified references. The slides run from a causal-loop diagram linking rainfall, vegetation, rodent density, and human intrusion, through a CDC surveillance chart of annual US case counts from 1993 to 2024, to a risk matrix covering cabins, farms, fieldwork, sheds, and disturbed habitats. Evidence is deliberately separated from hypothesis: the surveillance chart distinguishes finalized from provisional counts, the future-risk slide is labelled illustrative rather than a calibrated forecast, and the closing slide splits three cited surprises from three genuinely open questions.
Data sources
- CDC hantavirus case data and the National Notifiable Diseases Surveillance System, 1993-2024
- Afzal et al., Frontiers in Microbiology (2023) — global epidemiology, reservoirs, and case fatality rates
- Yates et al., BioScience (2002) — El Niño, rodent density, and Sin Nombre virus
- Luis, Kuenzi and Mills, PNAS (2018) — dilution and amplification mechanisms
- Martinez et al. (2005) on Andes virus person-to-person transmission and Hardestam et al. (2007) on environmental persistence
- Mertz et al. (2004) placebo-controlled ribavirin trial and Dietl et al. (2008) on extracorporeal membrane oxygenation
- CDC MMWR (2012) on the Yosemite tent-cabin cluster, the WHO hantavirus fact sheet, and OSHA occupational guidance
Limitations
Recent US case counts are provisional and are not finalized until roughly six months after year-end, and the CDC notes that reporting completeness and timeliness vary by state, so true incidence is likely understated. The global infection figure is an order-of-magnitude synthesis estimate rather than a direct measurement.
How this research was produced
K-Dense Web planned and ran this public health investigation end to end — gathering the sources, carrying out the analysis, producing the figures, and drafting the report. The full session transcript, including every intermediate step, is available to view.
